Europe – A Mature Market with Strong Research Capabilities
Europe represents the second-largest market in the Radiopharmaceuticals Market , valued at USD 2.13 billion in 2024 and holding a 30% global share. The region's growth is driven by a strong research infrastructure, increasing incidence of chronic diseases, and growing adoption of precision medicine. The European market is characterized by robust regulatory frameworks, extensive...
0 Kommentare 0 Anteile 44 Ansichten 0 Vorschau